$1 billion Ohmeda goes to Becton, Baxter and Datex-Engstrom
This article was originally published in Clinica
Executive Summary
The BOC Group has finally been able to divest itself of the Ohmeda healthcare business, by splitting the company into three and selling to Becton Dickinson, Baxter International and Finnish company Instrumentarium's Datex-Engstrom.